CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 190 enrolled
Drug / intervention
Medication Therapy Management +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02937545
NCT02937545N/ACompleted

Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting

Duke University·interventional·Posted Oct 18, 2016·Updated Jun 3, 2021

In Brief

A clinical study evaluating Medication Therapy Management and Pharmacogenetic testing for Pharmacogenetics. Completed, enrolled 190 participants across 1 site.

Detailed Summary

This study aims to compare patient use of and satisfaction with community pharmacist-delivered pharmacogenetic (PGx) testing delivered along or as part of a medication therapy management (MTM) service. Pharmacist and patient outcome measures will be collected by surveys, interviews, and review of pharmacy records.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 18, 2016
Enrollment StartFeb 22, 2017
Primary CompletionSep 10, 2019
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 9.7 years ago

Interventions

Medication Therapy Managementother

Community pharmacists will provide medication therapy management in combination with pharmacogenetic testing

Pharmacogenetic testingother

Community pharmacist will provide pharmacogenetic testing.